Finance

Lists
000538:SHE
Yunnan Baiyao Group Co Ltd
53,08 CNY
+0,34%
(+0,18) 1D
16 ოქტ, 15:04:30 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000538...
Open
52,89 CNY
High
53,66 CNY
Low
52,52 CNY
Mkt. cap
94,71 მლრდ.
Avg. vol.
7,52 მლნ.
Volume
12,92 მლნ.
Dividend
4,94%
Quarterly dividend
0,66 CNY
Ex-dividend date
30 აპრ. 2026
P/E ratio
18,14
52-wk high
58,20 CNY
52-wk low
46,29 CNY
EPS
2,93 CNY
Shares outstanding
1,78 მლრდ.
No. of employees
9 ათ.
Open
52,89 CNY
High
53,66 CNY
Low
52,52 CNY
Mkt. cap
94,71 მლრდ.
Avg. vol.
7,52 მლნ.
Volume
12,92 მლნ.
Dividend
4,94%
Quarterly dividend
0,66 CNY
Ex-dividend date
30 აპრ. 2026
P/E ratio
18,14
52-wk high
58,20 CNY
52-wk low
46,29 CNY
EPS
2,93 CNY
Shares outstanding
1,78 მლრდ.
No. of employees
9 ათ.
News stories
From web sources and news partners
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd
CEO-
Employees9,29 ათ.
Founded1902
Headquarters-
SectorPharmaceutical industry
Websiteyunnanbaiyao.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
9,40 მლრდ.
10,53 მლრდ.
11,60 მლრდ.
10,28 მლრდ.
Cost of goods sold
6,70 მლრდ.
7,85 მლრდ.
8,05 მლრდ.
7,28 მლრდ.
Cost of revenue
6,70 მლრდ.
7,85 მლრდ.
8,05 მლრდ.
7,28 მლრდ.
Research and development expenses
79,10 მლნ.
115,55 მლნ.
76,79 მლნ.
112,78 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,39 მლრდ.
2,37 მლრდ.
1,28 მლრდ.
1,50 მლრდ.
Operating expense
1,33 მლრდ.
2,67 მლრდ.
1,44 მლრდ.
1,64 მლრდ.
Total operating expenses
8,03 მლრდ.
10,52 მლრდ.
9,48 მლრდ.
8,92 მლრდ.
Operating income
1,37 მლრდ.
12,79 მლნ.
2,12 მლრდ.
1,36 მლრდ.
Other non operating income
-43,28 მლნ.
135,88 მლნ.
-17,44 მლნ.
37,87 მლნ.
EBT including unusual items
1,38 მლრდ.
428,17 მლნ.
2,36 მლრდ.
1,92 მლრდ.
EBT excluding unusual items
1,47 მლრდ.
233,79 მლნ.
2,35 მლრდ.
1,74 მლრდ.
Income tax expense
238,66 მლნ.
27,40 მლნ.
330,30 მლნ.
255,01 მლნ.
Effective tax rate
17,25%
6,40%
13,99%
13,27%
Other operating expenses
-18,86 მლნ.
129,96 მლნ.
6,54 მლნ.
116,66 მლნ.
Net income
1,14 მლრდ.
376,37 მლნ.
2,04 მლრდ.
1,66 მლრდ.
Net profit margin
12,18%
3,57%
17,56%
16,18%
Earnings per share
0,61
0,18
1,10
0,87
Interest and investment income
136,98 მლნ.
107,27 მლნ.
253,40 მლნ.
367,65 მლნ.
Interest expense
-4,39 მლნ.
-8,83 მლნ.
-5,09 მლნ.
-5,15 მლნ.
Net interest expenses
132,58 მლნ.
98,43 მლნ.
248,31 მლნ.
362,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,42 მლრდ.
70,91 მლნ.
2,18 მლრდ.
1,43 მლრდ.
Gain or loss from assets sale
2,26 მლნ.
-8,17 მლნ.
-
-3,05 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები